Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to \>75% of the baseline disease severity, will be investigated for response to further treatment with alitretinoin. Also, patients who have responded with mild or moderate disease will be investigated for additional treatment effect after prolongated treatment.
Epistemonikos ID: db3bed886162a4cec6588cb0e74b20f14a8fa346
First added on: May 04, 2024